Results 291 to 300 of about 57,277 (349)

Author's response to letter to the editor: “How culture shapes subjective cognitive decline reporting: Refining assessment tools with digital solutions”

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Sarah Tomaszewski Farias
wiley   +1 more source

CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain. [PDF]

Stem Cell Res Ther
Hermans EC, Donega V, Heijnen CJ, de Theije CGM, Nijboer CH.   +4 more
europepmc   +1 more source

Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model

, 2011
Sharareh Eskandari, Jaleh Varshosaz, Mohsen Minaiyan, et al.   +3 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Intranasal delivery of biotechnology-based therapeutics

Drug Discovery Today, 2022
Biotechnology-based therapeutics include a wide range of products, such as recombinant hormones, stem cells, therapeutic enzymes, monoclonal antibodies, genes, vaccines, among others. The administration of these macromolecules has been studied via various routes.
Dhrumi, Patel, Bharvi, Patel, Sarika, Wairkar   +2 more
openaire   +2 more sources

Intranasal Drug Delivery

Clinical Research and Regulatory Affairs, 1993
AbstractThe intranasal administration of drugs is a promising alternative to parenteral administration. The nasal route represents an interesting alternative for drugs which have low oral bioavailability because of degradation in GI tract or extensive mucosal or first-pass metabolism.
H. Zia, P. Dondeti, T. E. Needham
openaire   +1 more source